By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Alcon Laboratories, Inc. 

6201 South Freeway

Fort Worth  Texas  76134  U.S.A.
Phone: 800-451-3937-or-817-293-0450 Fax: 817-551-4615


Medical Device

Company News
Alcon (ACL) Announces EU Launch Of Cypass Micro-Stent, A Micro Invasive Glaucoma Surgical Device, To Lower Intraocular Pressure (IOP) In Patients With Primary Open-Angle Glaucoma 4/26/2017 10:53:30 AM
Novartis AG (NVS) Hires Bank of America (BAC) to Officially Review Alcon (ACL) Options 4/21/2017 5:32:06 AM
Novartis AG (NVS) Ponders Over Spin Off, IPO of Alcon (ACL) Eye Unit 1/25/2017 5:46:53 AM
Alcon (ACL) Receives US FDA Approval for AcrySof IQ ReSTOR +3.0D Multifocal Toric Intraocular Lens for Cataract Patients 12/27/2016 6:32:05 AM
Argentum And Alcon (ACL) Settle Patent Dispute Over PAZEO 12/1/2016 10:54:51 AM
Novartis AG (NVS) Weighs Sale of Its Alcon (ACL) Eye Care Biz 11/14/2016 7:26:03 AM
Alcon (ACL) Introduces New AIR OPTIX Plus Hydraglyde Monthly Replacement Contact Lenses At American Academy of Ophthalmology Annual Meeting 11/11/2016 2:40:27 PM
Turning Around Novartis AG (NVS)'s Struggling Alcon (ACL) Unit Will Take Longer Than Expected 10/26/2016 7:06:05 AM
Novartis AG (NVS) Says Anything is Possible in Regards to Selling Its Struggling Alcon (ACL) Biz 9/16/2016 6:40:07 AM
Alcon (ACL) Wins FDA Approval for Cypass Micro-Stent, A Micro Invasive Surgical Device to Treat Glaucoma 8/3/2016 10:16:09 AM